Interview for TheBody.com
I have to thank TheBody.com for the opportunity to tell my story https://thebody.com/multidrug/stories_nelson.html
Interview for TheBody.com Read More »
I have to thank TheBody.com for the opportunity to tell my story https://thebody.com/multidrug/stories_nelson.html
Interview for TheBody.com Read More »
I have received emails in the past about people asking why they feel anxious or moody on Ziagen. This problem has happened to me and others and it is rarely discussed in the literature or in physician-patient conversations. *********************** In response to the persons who said they cannot sleep and feel anxious on Epzicom (Ziagen+Epivir
Ziagen (Abacavir) Can Cause Anxiety in Some Patients Read More »
TOPIC: SURVIVING HIV RESISTANCE- How to avoid mistakes in using new HIV drugsReserve any lecture by calling 1-800- 810-3703 or email [email protected] TUESDAY, JUNE 12: MIAMI11 am- NoonJackson Health System1622 NW 12 Ave ACC West Room 125 WEDNESDAY, JUNE 13- PORT SAINT LUCIE10:30 am- noon5150 NW Milner Dr (off Midway Road)WEDNESDAY, JUNE 13- FORT LAUDERDALE6:30
LECTURES IN FLORIDA – JUNE 2007 Read More »
On March 20, Watson Laboratories stopped the production of nandrolone decanoate (old brand name: Deca Durabolin), a low cost injectable anabolic used for HIV wasting, citing lack of raw material suppliers for the product. Patients found out when they went to their pharmacies for a prescription a week later. Although there are other generic makers
Companies Abandon AIDS Wasting Patients Read More »
This was first brough to light by Michael Mooney in 1999. It took years but Serono is now paying for this troublesome corporate decision. You can read the original article in 1999 here: https://medibolics.com/kickback2.htm Ex-Serono executives acquitted in USA of bribing doctors 04/05/2007www.pharmatimes.com A federal grand jury has acquitted four former executives of Switzerland’s Serono,
Serono and Serostim’s Corruption Read More »
Copyright © 2006 Bay Area Reporter, a division of Benro Enterprises, Inc. AIDS activists upset by dropped wasting drugby Heather [email protected] AIDS activists are mobilizing after Watson Pharmaceuticals last month dropped a common off-label drug used to assist patients with combating wasting and picked up a generic brand of an approved AIDS-related wasting medication that
AIDS activists upset by dropped wasting drug Read More »
Surviving HIV Resistance in the new era of HAART Date: 04/25/2007 Time: 12-2 p.m. Place: Doubletree Hotel Address: 700 King St. City: Wilmington State: Delaware Zip: 19801 Contact Person: Lori Campbell Organization/Company: AIDS Delaware Contact Email: [email protected] Contact Phone: 302-652-6776 Contact Fax: Event Description: A lecture for patients and clinicians. Topics include how to avoid
My Upcoming Lecture in Wilmington , DE Read More »
Compounded medications have greatly improved the quality of the lives of many people living with HIV. Several of these medications (hormone therapies, wasting therapies, quality of life therapies) are not cover by most insurance or ADAP/Medicare/Medicaid formularies, so patients rely on access through compounding pharmacies. Now, access to these medications is facing a huge threat.
STOP CONGRESS FROM DENYING US COMPOUNDED MEDICINES Read More »
FOR MORE INFORMATION ABOUT THIS GO TO https://watsonboycott.blogspot.com/ April 4, 2007 Allen Chao, PhD Chairman and CEO Watson Pharmaceuticals Corporate Headquarters311 Bonnie CircleCorona, California 92880 Dear Dr Chao : I am writing to ask you to reverse your decision of stopping the manufacture of nandrolone decanoate. I am a national treatment advocate and person living
WATSON PHARMACEUTICALS ABANDONS AIDS WASTING DRUG Read More »
Title: Latest Update on HIV Research Seminar date : April 19, Thursday Time: 6:00 pm til 8:30 pm Free dinner and door prizes Speakers: Shannon Schrader MD Nelson Vergel (powerusa.org) LOCATION:United Way of the Texas Gulf Coast50 Waugh DriveHouston, Texas 77007 For more information email : [email protected]
Free HIV lecture in Houston on April 19, 2007 Read More »
From a meeting held by the Forum of Collaborative HIV Research. The list of participants is at the end of the letter. I certainly hope that the FDA encourages industry to implement these recommendations. Great ideas have died due to lack of action. March 11, 2007 The Forum for Collaborative HIV Research, an independent public/private
Please read the article written by Enid Vazquez in the latest Positively Aware, one of the main free HIV magazines distributed around the U.S. My comments are in the last part in the section called “Don’t do as I did” I want to make sure that people who are applying for TMC 125 expanded access
Do not do as I did Read More »